Shionogi says COVID pill trial shows reduction in symptoms




  • In Health
  • 2022-09-28 03:02:40Z
  • By Reuters
 

TOKYO (Reuters) -Japan's Shionogi & Co Ltd said on Wednesday its oral treatment for COVID-19 demonstrated a significant reduction in symptoms compared with a placebo in a Phase III trial in Asia.

The drug, a protease inhibitor known as ensitrelvir, met its primary endpoint in a trial conducted among predominantly vaccinated patients with mild to moderate cases of COVID-19, the company said in a statement.

Shionogi's shares reversed an early decline after the announcement, closing 1.1% higher in Tokyo versus a 1.5 drop in the benchmark Nikkei gauge.

Ensitrelvir met the trial's goal in reducing five key symptoms of the Omicron variant of COVID-19 within 72 hours of onset, the company said.

Regulatory authorities in Japan previously denied emergency approval for use of the pill, saying they wanted to see more data on its effectiveness. There are also concerns the drug could pose risk to pregnancies, based on results from animal studies.

Shionogi said it has shared top-line data from the Phase III study with Japanese regulators as part of deliberations on approval of the drug.

Shionogi has global aspirations for the drug, also known as S-217622 and by the brand name Xocova, which would compete with COVID-19 pills from Pfizer Inc and Merck & Co Inc that have already been approved in Japan and elsewhere.

The company has signed an agreement to sell about a million doses to the government, pending the drug's approval.

Chief Executive Isao Teshirogi has said annual production of the drug could reach 10 million doses. The firm has received U.S. government support for a global Phase III trial.

(Reporting by Rocky Swift; Editing by Christopher Cushing, Richard Pullin and Angus MacSwan)

COMMENTS

More Related News

Croatia World Cup 2022 results, squad list, fixtures and latest odds
Croatia World Cup 2022 results, squad list, fixtures and latest odds

Croatia have booked their place in the quarter finals after Zlatko Dalic's side beat Japan 3-1 on penalties.

Mercedes opens its first EV-only dealership in the world in Japan
Mercedes opens its first EV-only dealership in the world in Japan
  • US
  • 2022-12-06 09:28:47Z

Mercedes-Benz's first dealership in the world dedicated to its all-electric Mercedes-EQ brand opened in Yokohama, south of the Japanese capital on Tuesday...

Asian Stocks Mixed With Focus on Fed, China Covid: Markets Wrap
Asian Stocks Mixed With Focus on Fed, China Covid: Markets Wrap

(Bloomberg) -- Asian stocks were mixed as investors weighed unexpectedly strong US services data and China's accelerated moves toward exiting its Covid-Zero ...

Japan
Japan's Households Spend More Despite Accelerating Inflation

(Bloomberg) -- Japan's households boosted spending in October for a second straight month despite accelerating inflation and falling real wages, marking a...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Health